查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012715

血管造影术设备市场：按系统类型、检测器类型、应用和最终用户划分 - 2026-2032年全球市场预测

Angiography Equipment Market by System Type, Detector Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血管造影术设备市场价值将达到 140.8 亿美元，到 2026 年将成长至 149.6 亿美元，到 2032 年将达到 219.2 亿美元，复合年增长率为 6.52%。

主要市场统计数据
基准年 2025 140.8亿美元
预计年份：2026年 149.6亿美元
预测年份 2032 219.2亿美元
复合年增长率 (%) 6.52%

简要概述诊断影像的准确性、介入治疗需求和经济压力如何重新定义血管造影术系统的采购和临床应用。

血管造影术系统代表了现代医疗服务中影像精度、介入能力和系统级整合三者的完美结合。本执行摘要概述了影响整个诊断和介入领域采购、临床部署和技术进步的关键趋势。它探讨了系统结构、检测器技术和临床应用如何整合，从而对剂量管理、工作流程效率以及与电子健康记录的互通性提出了新的要求。

数位检测器、人工智慧成像和混合手术工作流程的进步如何融合，重新定义血管造影术系统的临床效用和采购重点。

在血管造影术领域，技术成熟、临床路径不断演进以及生态系统内伙伴关係的推动下，变革正在发生。在许多临床环境中，数位平板检测器技术正在取代传统的影像增强管系统，从而提高影像品质和剂量效率，使更复杂、微创的手术成为可能。同时，软体方面的进步，从即时降噪和血管增强到利用扩增实境（AR）迭加技术进行手术指导，正在增强医生的信心并缩短手术时间。

美国关税政策变化对製造商和医疗保健提供者的血管造影术系统采购、定价和筹资策略的多方面连锁反应。

美国2025年实施的贸易政策转变与关税调整，为血管造影术设备的供应链与筹资策略增添了新的复杂性。这些措施影响了製造和分销管道的成本结构，并推高了部分进口组件和成品的价格，同时也促进了某些生产活动的回流（将生产迁回本国）和近岸外包（将生产转移到邻国）。在组装和校准过程中，专用检测器面板、精密马达和专有软体模组需要多次跨境，因此这些措施的累积影响最为显着。

从洞察深刻、以细分为导向的观点系统结构、检测器技术、临床应用和最终用户优先权与可操作的产品和服务策略连结起来。

详细的市场区隔揭示了临床需求、技术选择和采购行为之间的交集，为供应商和医疗系统提供了切实可行的见解。根据系统类型，市场可分为双平面系统和单平面系统。双平面系统在需要同时进行正交成像的复杂神经血管和复杂结构介入手术中越来越受欢迎，而单平面系统由于其面积效率和成本优势，在高通量心血管和外周介入手术室中仍然占据主导地位。根据检测器类型，在优先考虑影像解析度和剂量效率的环境中，平板检测器的使用率显着提高，而影像增强器系统在患者量较少或预算有限、优先考虑可靠性和低初始投资的医疗机构中仍然发挥着至关重要的作用。

区域医疗基础设施、报销制度和设备扩容如何影响血管造影术设备的采用趋势和商业策略？

区域趋势正以不同的方式影响血管造影术系统的应用路径和竞争定位。在美洲，大规模医院网路、心臟病学和介入放射学的高检查量，以及对人工智慧辅助成像和与混合手术室相容等先进功能的需求，都在影响着投资模式。该地区的报销框架和资本预算流程往往侧重于已证实的临床和经济效益，从而鼓励医疗机构优先选择兼具性能和生命週期价值的系统。

我们在血管造影术领域的竞争优势源于一个整合的硬体和软体生态系统，有助于技术的采用、本地化的卓越服务以及经过验证的临床伙伴关係。

血管造影术设备市场的竞争格局以产品差异化、服务生态系统和策略伙伴关係为特征。主要企业正着力打造整合解决方案，将高效能成像硬体与先进的软体工具集结合，用于工作流程协调、远距离诊断和手术规划。这种系统级方案使供应商能够透过服务合约、软体订阅和耗材销售获得持续收入，同时为客户提供可预测的生命週期成本。

为製造商和医疗保健领导者提供切实可行的策略建议，以加速血管摄影检查系统的采用，减少采购摩擦，并提高临床价值的实现。

产业领导者需要调整其商业策略，使其与不断变化的临床需求和采购行为相适应，从而在血管造影术生态系统中实现永续价值。首先，他们应优先考虑模组化和可升级的产品架构，以便在不更换整个系统的情况下分阶段引入先进的检测器单元、软体功能和手术辅助设备。这将降低采购门槛，并减轻关税对价格波动的影响。其次，他们应投资于嵌入式的临床决策支援和手术指导工具，这些工具可以显着缩短手术时间、造影造影剂用量和辐射曝射量。临床证据和同行评审的检验结果很可能对怀疑的买家产生重大影响，促使他们接受这些工具。

透过结合与专家的初步访谈、系统性的次要分析和三角检验，高度透明和多方面的调查方法确保了可重复和引人注目的见解。

我们的调查方法结合了对医疗保健相关人员的结构化一手访谈、对二手资讯的全面整合以及严谨的检验验证，从而确保了研究结果的可靠性和可操作性。一手研究包括对介入性心臟病专家、介入神经放射学专家、放射科医生、生物医学工程师、采购主管和独立服务机构的深入访谈，旨在了解他们对临床需求、服务期望和采购行为的实际观点。这些访谈旨在获取关于系统性能、维护经验和决策标准的真实见解。

一项权威的综合分析突显了供应商和医疗保健提供者在不断发展的血管造影术领域中，在协调创新、服务和采购方面所面临的战略挑战。

总之，在检测器技术进步、内建软体功能增强以及临床工作流程向混合和微创方法转变的推动下，血管造影术系统目前正经历着重大变革。能够提供模组化架构、检验的临床决策支援和完善服务模式的供应商，最能满足医院、专科诊所和诊断中心的多样化需求。贸易政策和关税趋势凸显了灵活采购和商业条款的重要性，有助于保护客户免受成本快速波动的影响，同时维持供应商的利润率。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章血管造影术设备市场（依系统类型划分）

  • 双翼飞机
  • 单翼飞机

第九章：检测器类型分類的血管造影术设备市场

  • 平板
  • 影像增强器

第十章血管造影术设备市场：依应用领域划分

  • 循环系统
    • 冠状动脉
    • 外围
  • 神经病学
    • 脑
    • 脊髓
  • 放射科
    • 腹部
    • 外围

第十一章血管造影术设备市场：依最终用户划分

  • 诊断中心
  • 医院
  • 专科诊所

第十二章血管造影术设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章血管造影术设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章血管造影术设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国血管造影术设备市场

第十六章 中国血管造影术器械市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Carestream Health Inc.
  • Electron Co.
  • GE Healthcare
  • General Electric Company
  • Hitachi Medical Systems Corporation
  • Koninklijke Philips NV
  • Koninklijke Philips NV
  • Medical Warehouse
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Toshiba Corporation
Product Code: MRR-43690106627D

The Angiography Equipment Market was valued at USD 14.08 billion in 2025 and is projected to grow to USD 14.96 billion in 2026, with a CAGR of 6.52%, reaching USD 21.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.08 billion
Estimated Year [2026] USD 14.96 billion
Forecast Year [2032] USD 21.92 billion
CAGR (%) 6.52%

A concise orienting overview of how imaging precision, interventional demand, and economic pressures are redefining procurement and clinical use of angiography systems

Angiography equipment sits at the intersection of imaging precision, interventional capability, and system-level integration within modern healthcare delivery. This executive summary distills the pivotal dynamics shaping procurement, clinical adoption, and technology evolution across diagnostic and interventional suites. It examines how system architectures, detector technologies, and clinical applications are converging to drive new requirements for dose management, workflow efficiency, and interoperability with electronic health records.

Clinicians demand higher spatial and temporal resolution to support complex procedures in cardiology, neurology, and radiology, while hospital administrators prioritize lifecycle costs, throughput, and downstream revenue capture. Simultaneously, suppliers are advancing digital detectors, AI-enabled image enhancement, and modular service offerings to meet heterogeneous customer needs. The interplay between clinical imperatives and capital constraints is producing differentiated value propositions that favor flexible financing, managed service models, and retrofit pathways for legacy installations.

This introduction frames subsequent sections that explore transformative shifts in the technology landscape, regulatory and trade policy impacts, segmentation-driven opportunities, regional patterns of adoption, competitive behavior among device manufacturers, and pragmatic recommendations for healthcare providers and suppliers aiming to navigate this rapidly evolving domain.

How digital detector advances, AI-enabled imaging, and hybrid procedural workflows are converging to redefine clinical utility and procurement priorities for angiography systems

The angiography landscape is experiencing transformative shifts driven by technological maturation, clinical pathway evolution, and ecosystem partnerships. Digital flat detector technology has steadily supplanted legacy image intensifier systems in many clinical environments, yielding improved image quality and dose efficiency that enable more complex minimally invasive procedures. Parallel advances in software-ranging from real-time noise reduction and vessel enhancement to procedural guidance using augmented overlays-are enhancing operator confidence and reducing procedure times.

At the same time, the boundaries between imaging equipment, informatics, and procedural devices are blurring. Integration with electronic health records and picture archiving systems is becoming table stakes, while open architectures and standardized data formats facilitate third-party analytics, remote monitoring, and predictive maintenance. Artificial intelligence is moving from pilot projects to embedded features that assist in anatomy segmentation, device navigation, and quality control, thereby improving consistency across operators and sites.

Clinical practice trends are also reshaping demand profiles. Interventionalists increasingly prefer systems that support hybrid procedures, allowing seamless transitions between diagnostic imaging and complex interventions. This has elevated interest in biplane systems for certain neurovascular and structural heart procedures, while monoplane systems are optimized for high-volume cardiology and peripheral workflows. Together, these forces are prompting manufacturers and healthcare providers to rethink procurement criteria, capital allocation, and long-term service agreements.

The multifaceted ripple effects of US tariff policy changes on sourcing, pricing, and procurement strategies for angiography systems across manufacturers and healthcare providers

Trade policy shifts and tariff adjustments introduced in the United States in 2025 added a new dimension of complexity to supply chain and procurement strategies for angiography equipment. These measures influenced cost structures along manufacturing and distribution channels, creating upward pressure on component and finished-system prices for some imported assemblies while incentivizing reshoring and nearshoring of select production activities. The cumulative impact has been most pronounced where specialized detector panels, precision motors, and proprietary software modules cross borders multiple times during assembly and calibration.

As a result, original equipment manufacturers reassessed sourcing footprints and supplier contracts to mitigate tariff exposure. Several providers accelerated dual-sourcing strategies and invested in qualifying local suppliers for critical subassemblies to preserve delivery timelines and stabilize pricing for major healthcare clients. Hospitals and integrated delivery networks responded by intensifying vendor negotiations, seeking favorable service terms, and evaluating total cost of ownership more rigorously, including spare parts availability and long-term maintenance commitments.

Procurement teams also began to place higher value on modular product designs that allow phased upgrades without full-system replacement, thereby reducing capital outlays that are sensitive to tariff-induced price volatility. In parallel, distributors and systems integrators adapted commercial models to offer expanded financing, extended warranties, and inventory pooling solutions that buffer customers from sudden cost escalations. These market adaptations highlight the interconnectedness of trade policy, manufacturing strategy, and clinical technology adoption.

Insightful segmentation-driven perspectives linking system architecture, detector technology, clinical application, and end-user priorities to actionable product and service strategies

Granular segmentation illuminates where clinical needs intersect with technology choice and procurement behaviors, offering actionable insight for suppliers and health systems. Based on system type, the landscape separates into biplane systems, which are increasingly favored for complex neurovascular and combined structural interventions that demand simultaneous orthogonal imaging, and monoplane systems, which continue to dominate high-throughput cardiology and peripheral interventional suites due to their footprint efficiency and cost profile. Based on detector type, the shift toward flat panel detectors is evident in settings that prioritize image resolution and dose efficiency, while image intensifier systems remain relevant in lower-volume or budget-constrained facilities that prioritize proven reliability and lower immediate capital expenditure.

Based on application, clinical demand patterns vary: cardiology drives a large share of procedure volume and favors systems optimized for coronary and peripheral vascular access, neurology requires specialized neuro-vascular capabilities tailored to cerebral and spinal interventions with high spatial resolution and rapid imaging sequences, and radiology applications focus on abdominal and peripheral vascular work where contrast dynamics and soft-tissue visualization are critical. Based on end user, diagnostic centers emphasize throughput and serviceability to support ambulatory care models, hospitals require scalable platforms that integrate into surgical and hybrid operating rooms while balancing capital constraints and multidisciplinary use, and specialty clinics prioritize compact, procedure-specific systems that deliver procedural efficiency and straightforward maintenance.

Understanding these segmentation lenses in combination enables suppliers to tailor product roadmaps, service packages, and pricing strategies that align with distinct clinical workflows and procurement cycles across customer cohorts.

How regional healthcare infrastructure, reimbursement mechanisms, and capacity expansion are driving differentiated adoption trends and commercial strategies for angiography equipment

Regional dynamics shape adoption pathways and competitive positioning for angiography equipment in distinct ways. In the Americas, investment patterns are influenced by large hospital networks, high procedure volumes in cardiology and interventional radiology, and an appetite for advanced features such as AI-assisted imaging and hybrid-suite compatibility. Reimbursement frameworks and capital budgeting processes in this region tend to favor demonstrable clinical and economic benefits, prompting providers to prioritize systems that offer both performance and lifecycle value.

In Europe, Middle East & Africa, heterogeneous healthcare infrastructures lead to a spectrum of adoption behaviors: advanced tertiary centers and academic hospitals invest in biplane and high-spec flat detector systems to support complex neurovascular and structural interventions, while mid-tier hospitals and clinics may favor monoplane or retrofittable solutions that balance capability with cost. Regulatory harmonization and cross-border procurement in certain subregions influence vendor strategies and create opportunities for service-based commercial models.

In Asia-Pacific, rapid expansion of procedural capacity, growing private healthcare sectors, and government-led investments in tertiary care facilities are driving demand for both new installations and upgrade pathways. High-volume centers prioritize throughput, remote serviceability, and local training partnerships, while emerging markets exhibit sensitivity to acquisition cost and aftermarket support, encouraging manufacturers to offer flexible financing and localized maintenance networks. These regional patterns underscore the need for nuanced go-to-market approaches that align product variants and commercial models with local clinical and economic realities.

Competitive differentiation in angiography emerges from integrated hardware-software ecosystems, localized service excellence, and validated clinical partnerships that drive adoption

Competitive dynamics among companies in the angiography equipment space are characterized by product differentiation, service ecosystems, and strategic partnerships. Leading manufacturers emphasize integrated solutions that couple high-performance imaging hardware with advanced software toolsets for workflow orchestration, remote diagnostics, and procedure planning. This systems-level approach allows vendors to capture recurring revenue through service contracts, software subscriptions, and consumables while offering customers predictable lifecycle costs.

Strategic alliances with clinical centers and academic institutions play a critical role in validating technology and accelerating clinical acceptance, particularly for innovations such as AI-enabled image guidance and dose-optimization algorithms. In addition, regional distributors and service partners contribute materially to market penetration by providing localized training, rapid maintenance response, and spare-part inventories that sustain uptime in high-volume procedural settings.

Smaller and niche suppliers find opportunities by focusing on specialized segments-such as compact systems for outpatient clinics, retrofit detector solutions for legacy C-arms, or dedicated neurovascular platforms-where agile product development and targeted service offerings can outmaneuver broader incumbents. Across the competitive landscape, clear differentiation arises from demonstrated clinical outcomes, total cost of ownership transparency, and the ability to support multidisciplinary use cases within contemporary hybrid operating environments.

Practical and strategic recommendations for manufacturers and healthcare leaders to accelerate adoption, reduce procurement friction, and enhance clinical value delivery for angiography systems

Industry leaders should align commercial strategies with evolving clinical demands and procurement behaviors to capture sustainable value in the angiography ecosystem. First, prioritize modular and upgradable product architectures that allow customers to phase in advanced detector units, software capabilities, and procedural adjuncts without full-system replacement, thereby lowering barriers to purchase and reducing sensitivity to tariff-driven price volatility. Second, invest in embedded clinical decision support and procedure guidance tools that demonstrably reduce procedure time, contrast usage, and radiation dose; clinical evidence and peer-reviewed validation will materially influence adoption among skeptical buyers.

Third, develop flexible commercial models including managed services, outcome-linked pricing, and extended warranties that address capital constraints and shift some performance risk away from buyers. Fourth, strengthen local service networks and spare-part distribution in strategic regions to improve uptime guarantees and build trust with high-volume centers. Fifth, cultivate academic and clinical center partnerships to co-develop workflow-optimized solutions and to generate real-world evidence supporting improved clinical outcomes. Finally, enhance interoperability with hospital informatics and third-party analytics platforms to ensure seamless integration into enterprise imaging strategies and to unlock value from procedural data for quality improvement and research initiatives.

A transparent, multi-source research methodology blending expert primary interviews, systematic secondary analysis, and triangulation to ensure replicable and defensible insights

Our research methodology combined structured primary engagement with healthcare stakeholders, comprehensive secondary-source synthesis, and rigorous triangulation to ensure robust and actionable findings. Primary research included in-depth interviews with interventional cardiologists, neurointerventionalists, radiologists, biomedical engineers, procurement executives, and independent service organizations to capture frontline perspectives on clinical requirements, service expectations, and purchasing behavior. These conversations were designed to surface unfiltered insights on system performance, maintenance experience, and decision criteria.

Secondary research involved a systematic review of publicly available regulatory approvals, clinical literature, professional society guidelines, and industry white papers to contextualize technological developments and procedural trends. Data triangulation merged qualitative insights with product release timelines, patent activity, and supplier announcements to validate adoption signals and strategic direction across manufacturers. Emphasis was placed on reproducibility: methodologies and interview frameworks were documented, and findings were cross-checked against multiple independent sources.

Limitations of the methodology include variability in regional reporting practices and the evolving nature of software-enabled features that may reach different markets at different times. To mitigate these factors, sensitivity assessments were applied when drawing conclusions about supply chain adjustments and regional adoption patterns.

A decisive synthesis highlighting the strategic imperatives for suppliers and healthcare providers to align innovation, service, and procurement in the evolving angiography domain

In conclusion, angiography equipment is undergoing a period of substantive transformation driven by advances in detector technology, embedded software capabilities, and changing clinical workflows that favor hybrid and minimally invasive approaches. Suppliers that offer modular architectures, validated clinical decision support, and resilient service models will be best positioned to meet the nuanced needs of hospitals, specialty clinics, and diagnostic centers. Trade policy and tariff developments have underscored the importance of flexible sourcing and commercial terms that protect customers from abrupt cost shifts while preserving supplier margins.

Regional adoption patterns vary, requiring tailored strategies that reflect reimbursement environments, infrastructure maturity, and local service expectations. Segmentation across system type, detector type, clinical application, and end user offers a practical framework for prioritizing product development and go-to-market investments. Ultimately, success in this market hinges on the ability to deliver demonstrable clinical value, predictable lifecycle economics, and seamless integration into existing enterprise workflows. Stakeholders who align innovation roadmaps with these imperatives will accelerate adoption, improve procedural outcomes, and capture long-term commercial advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Angiography Equipment Market, by System Type

  • 8.1. Biplane
  • 8.2. Monoplane

9. Angiography Equipment Market, by Detector Type

  • 9.1. Flat Panel
  • 9.2. Image Intensifier

10. Angiography Equipment Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Coronary
    • 10.1.2. Peripheral
  • 10.2. Neurology
    • 10.2.1. Cerebral
    • 10.2.2. Spinal
  • 10.3. Radiology
    • 10.3.1. Abdominal
    • 10.3.2. Peripheral

11. Angiography Equipment Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Angiography Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Angiography Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Angiography Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Angiography Equipment Market

16. China Angiography Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Boston Scientific Corporation
  • 17.7. Boston Scientific Corporation
  • 17.8. Canon Medical Systems Corporation
  • 17.9. Canon Medical Systems Corporation
  • 17.10. Cardinal Health, Inc.
  • 17.11. Carestream Health Inc.
  • 17.12. Electron Co.
  • 17.13. GE Healthcare
  • 17.14. General Electric Company
  • 17.15. Hitachi Medical Systems Corporation
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Medical Warehouse
  • 17.19. Medtronic plc
  • 17.20. MicroPort Scientific Corporation
  • 17.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.22. Shimadzu Corporation
  • 17.23. Shimadzu Corporation
  • 17.24. Siemens Healthineers AG
  • 17.25. Stryker Corporation
  • 17.26. Terumo Corporation
  • 17.27. Toshiba Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY BIPLANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY BIPLANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY BIPLANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY MONOPLANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY MONOPLANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY MONOPLANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY FLAT PANEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY FLAT PANEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY FLAT PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CEREBRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CEREBRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CEREBRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)